All In Biotech

Drug Trial Radar · NCT04138277

A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD)

A Phase 3 Open-label Extension Study to Assess the Long-term Safety and Efficacy of Intravenous ATB200 Co-administered With Oral AT2221 in Adult Subjects With Late-onset Pompe Disease (LOPD)

Last checked: Nov 19, 2026Latest source record: Mar 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

119

Actual

Start

Dec 18, 2019

Primary completion

Dec 31, 2024

Study completion Dec 31, 2024

Sponsor

Lead sponsor
Amicus TherapeuticsIndustry
Sponsor type
Industry
First posted
Oct 24, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, international open-label extension study of ATB200/AT2221 in adult subjects with late-onset Pompe disease (LOPD) who completed Study ATB200-03.

Conditions

  • Pompe Disease (Late-onset)

Interventions

  • AT2221Drug

    Participants received ATB200 co-administered with AT2221 (miglustat)

  • ATB200Biological

    Enzyme Replacement Therapy via intravenous infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Treatment-emergent Adverse Events (TEAEs), Treatment-emergent Serious Adverse Events (TESAEs), and TEAEs Leading to Discontinuation of Study DrugTime frame: Entire extension study (mean = 40.5 months on treatment)

Locations

60 sites in 23 countries. Site status is shown where the registry gives one.

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • University of California, Irvine

    Irvine, California

  • University of Florida Clinical Research Center

    Gainesville, Florida

  • Emory Clinic

    Atlanta, Georgia

  • IU Health Neuroscience Center

    Indianapolis, Indiana

  • Washington University School of Medicine

    St Louis, Missouri

  • Billings Clinic

    Billings, Montana

  • Hackensack University Medical Center

    Hackensack, New Jersey

  • Northwell Health

    Great Neck, New York

  • NYU School of Medicine

    New York, New York

  • Duke University Medical Center

    Durham, North Carolina

  • University of Cincinnati Gardner Neuroscience Institute

    Cincinnati, Ohio

  • Cincinnati Children's Hospital

    Cincinnati, Ohio

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • UPMC Montefiore Clinical and Translational Research Center

    Pittsburgh, Pennsylvania

  • University of Utah

    Salt Lake City, Utah

  • Lysosomal and Rare Disorders Research and Treatment Center, Inc.

    Fairfax, Virginia

  • Hospital Universitario Austral

    Buenos Aires, Argentina

  • Westmead Hospital

    Westmead, New South Wales, Australia

  • Royal Brisbane & Women's Hospital

    Brisbane, Queensland, Australia

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia

  • Monash Medical Centre

    Clayton, Victoria, Australia

  • Medizinische Universität Innsbruck

    Innsbruck, Austria

  • UZ Leuven

    Leuven, Belgium

  • University Clinical Centre of the Republic of Srpska

    Banja Luka, The Republic of Srpska, Bosnia and Herzegovina

  • Alberta Children's Hospital, Heritage Medical Research Clinic

    Calgary, Alberta, Canada

  • McMaster University Medical Centre

    Hamilton, Ontario, Canada

  • Aarhus Universitetshospital

    Aarhus, Denmark

  • Hôpital Pierre Wertheimer

    Bron, France

  • Hôpital Raymond Poincaré

    Garches, France

  • Hôpital Salengro

    Lille, France

  • Hôpital de la Timone

    Marseille, France

  • Hôpital Pasteur 2

    Nice, France

  • Universitätsklinikum Bonn

    Bonn, Germany

  • Friedrich-Baur Institut

    München, Germany

  • Universitätsklinikum Münster

    Münster, Germany

  • Eginition Hospital

    Athens, Greece

  • Semmelweis University

    Budapest, Hungary

  • University of Pécs

    Pécs, Hungary

Showing 40 of 60 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.